IDenta Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IDTA research report →
About the company
IDenta Corp. operates as a detection and forensic science company. The company offers drug testing kits, explosives testing kits, aero chamber sniffer, forensic, urine drug testing, and saliva drug testing products.
- CEO
- Amichai Glattstein
- IPO
- 2017
- Employees
- 16
- HQ
- Jerusalem, IL
Price Chart
- Market Cap
- $1.11M
- P/E
- 5.84
- P/S
- 0.66
- P/B
- 1.16
- EV/EBITDA
- 6.47
- Div Yield
- 0.00%
- Gross Margin
- 53.20%
- Op Margin
- 21.22%
- Net Margin
- 11.29%
- ROE
- 22.21%
- ROIC
- 21.55%
- Revenue
- $1.34M · -7.86%
- Net Income
- $99.04K · -61.66%
- EPS
- $0.02 · -61.66%
- Op Income
- $185.37K
- FCF YoY
- -92.75%
- 52W High
- $0.50
- 52W Low
- $0.15
- 50D MA
- $0.18
- 200D MA
- $0.20
- Beta
- 0.59
- Avg Volume
- 322
Get TickerSpark's AI analysis on IDTA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our IDTA coverage
Recent articles, reports, and earnings notes.
No research on IDTA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IDTA report →Similar companies
Peers in the same neighborhood.